# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Brendan Smith maintains Novavax (NASDAQ:NVAX) with a Hold and raises the price target from $5 to $10.
HC Wainwright & Co. analyst Vernon Bernardino reiterates Novavax (NASDAQ:NVAX) with a Buy and maintains $19 price target.
B of A Securities analyst Alec Stranahan upgrades Novavax (NASDAQ:NVAX) from Underperform to Neutral and raises the price ta...
Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.